Global Hemp Group Inc. (GHG.CN)
CAD 0.02
(-33.33%)
CAD 0.02
(-33.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 551.7 Thousand CAD | 398.29% |
| 2022 | -184.95 Thousand CAD | -106.38% |
| 2021 | 2.89 Million CAD | 299.68% |
| 2020 | 725.48 Thousand CAD | -71.46% |
| 2019 | 2.54 Million CAD | 101.24% |
| 2018 | 1.26 Million CAD | 59.36% |
| 2017 | 792.53 Thousand CAD | 1101.39% |
| 2016 | 65.96 Thousand CAD | -79.02% |
| 2015 | 314.48 Thousand CAD | -87.97% |
| 2014 | 2.61 Million CAD | 3847.85% |
| 2013 | 66.2 Thousand CAD | 56873.81% |
| 2012 | 116.20 CAD | -99.92% |
| 2011 | 137.93 Thousand CAD | 63.11% |
| 2010 | 84.56 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 60.37 Thousand CAD | -82.98% |
| 2024 Q3 | 82.01 Thousand CAD | 14.45% |
| 2024 Q2 | 71.65 Thousand CAD | 18.69% |
| 2023 Q2 | 116.54 Thousand CAD | 463.28% |
| 2023 Q3 | 90.17 Thousand CAD | -22.63% |
| 2023 Q4 | 354.73 Thousand CAD | 293.37% |
| 2023 FY | 555.67 Thousand CAD | 400.43% |
| 2023 Q1 | 20.69 Thousand CAD | 103.9% |
| 2022 Q3 | 231.29 Thousand CAD | 119.47% |
| 2022 Q1 | 119.07 Thousand CAD | -86.77% |
| 2022 FY | -184.95 Thousand CAD | -106.38% |
| 2022 Q2 | 105.39 Thousand CAD | -11.49% |
| 2022 Q4 | -529.9 Thousand CAD | -329.1% |
| 2021 Q2 | 1.02 Million CAD | 347.5% |
| 2021 FY | 2.89 Million CAD | 299.68% |
| 2021 Q3 | 761.11 Thousand CAD | -25.57% |
| 2021 Q4 | 900.09 Thousand CAD | 18.26% |
| 2021 Q1 | 228.5 Thousand CAD | 176.59% |
| 2020 Q2 | -6749.00 CAD | -100.68% |
| 2020 FY | 725.48 Thousand CAD | -71.46% |
| 2020 Q3 | 38 Thousand CAD | 663.09% |
| 2020 Q4 | -298.36 Thousand CAD | -885.12% |
| 2020 Q1 | 992.59 Thousand CAD | 237.25% |
| 2019 Q1 | 3.09 Million CAD | 181.67% |
| 2019 FY | 2.54 Million CAD | 101.24% |
| 2019 Q2 | 127.26 Thousand CAD | -95.88% |
| 2019 Q3 | 45.91 Thousand CAD | -63.92% |
| 2019 Q4 | -723.18 Thousand CAD | -1674.95% |
| 2018 Q1 | 77.73 Thousand CAD | -89.63% |
| 2018 Q4 | 1.09 Million CAD | 2375.56% |
| 2018 Q2 | 74.35 Thousand CAD | -4.36% |
| 2018 FY | 1.26 Million CAD | 59.36% |
| 2018 Q3 | 44.33 Thousand CAD | -40.37% |
| 2017 Q4 | 749.7 Thousand CAD | 6167.92% |
| 2017 Q2 | 22.5 Thousand CAD | 168.93% |
| 2017 Q1 | 8367.00 CAD | -52.96% |
| 2017 FY | 792.53 Thousand CAD | 1101.39% |
| 2017 Q3 | 11.96 Thousand CAD | -46.84% |
| 2016 Q4 | 17.78 Thousand CAD | 33.21% |
| 2016 Q3 | 13.35 Thousand CAD | -38.91% |
| 2016 Q1 | 12.97 Thousand CAD | -32.44% |
| 2016 Q2 | 21.85 Thousand CAD | 68.51% |
| 2016 FY | 65.96 Thousand CAD | -79.02% |
| 2015 FY | 314.48 Thousand CAD | -87.97% |
| 2015 Q4 | 19.2 Thousand CAD | -90.6% |
| 2015 Q3 | 204.29 Thousand CAD | 212.16% |
| 2015 Q2 | 65.44 Thousand CAD | 156.19% |
| 2015 Q1 | 25.54 Thousand CAD | -98.53% |
| 2014 Q2 | 407.34 Thousand CAD | 1221.86% |
| 2014 Q1 | 30.81 Thousand CAD | 38.96% |
| 2014 Q4 | 1.73 Million CAD | 291.69% |
| 2014 FY | 2.61 Million CAD | 3847.85% |
| 2014 Q3 | 443.08 Thousand CAD | 8.77% |
| 2013 Q2 | 11.31 Thousand CAD | -19.02% |
| 2013 Q1 | 13.96 Thousand CAD | -46.88% |
| 2013 FY | 66.2 Thousand CAD | 56873.81% |
| 2013 Q3 | 18.75 Thousand CAD | 65.78% |
| 2013 Q4 | 22.17 Thousand CAD | 18.27% |
| 2012 Q3 | 15.44 Thousand CAD | -98.31% |
| 2012 Q1 | 17.61 Thousand CAD | -56.07% |
| 2012 Q2 | 911.84 Thousand CAD | 5075.96% |
| 2012 Q4 | 26.29 Thousand CAD | 70.28% |
| 2012 FY | 116.20 CAD | -99.92% |
| 2011 Q3 | 31.75 Thousand CAD | -18.79% |
| 2011 Q1 | 26.98 Thousand CAD | 0.0% |
| 2011 Q2 | 39.09 Thousand CAD | 44.88% |
| 2011 FY | 137.93 Thousand CAD | 63.11% |
| 2011 Q4 | 40.1 Thousand CAD | 26.31% |
| 2010 Q3 | 20.4 Thousand CAD | 0.0% |
| 2010 FY | 84.56 Thousand CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -238.228% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | 95.291% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -555.041% |
| The BC Bud Corporation | 1.28 Million CAD | 56.998% |
| BioNxt Solutions Inc. | 6.73 Million CAD | 91.814% |
| CordovaCann Corp. | 3.86 Million CAD | 85.713% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | 87.119% |
| Captor Capital Corp. | 16.28 Million CAD | 96.612% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | 21.822% |
| 1CM Inc. | 7.3 Million CAD | 92.451% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 88.524% |
| IM Cannabis Corp. | 22.63 Million CAD | 97.563% |
| Lobe Sciences Ltd. | 4.13 Million CAD | 86.649% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -40.664% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -819.513% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | 68.795% |
| Ovation Science Inc. | 54.1 Thousand CAD | -919.793% |
| Pharmadrug Inc. | 1.33 Million CAD | 58.674% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | 57.737% |
| RAMM Pharma Corp. | 7.48 Million CAD | 92.625% |
| RIV Capital Inc. | 21.1 Million CAD | 97.386% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | 83.209% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 98.539% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 97.758% |
| 1933 Industries Inc. | 5.12 Million CAD | 89.235% |
| Red Light Holland Corp. | 2.02 Million CAD | 72.694% |
| Top Strike Resources Corp. | 3.63 Million CAD | 84.809% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 278.881% |
| Adastra Holdings Ltd. | 9.36 Million CAD | 94.106% |